CareSelect Blood enables benchmarking, clinical interventions, and reporting to impact acute areas of over-utilization for blood product transfusions
National Decision Support Company has partnered with Mayo Clinic to release CareSelect™ Blood, a patient blood management (PBM) solution that guides health care providers in the proper utilization of blood products, improves the patient care experience and reduces the cost of care.
The CareSelect Blood Advantage
CareSelect Blood delivers guidelines from Mayo Clinic, the largest integrated clinical practice in the world, to enable a standardization of care across the enterprise. Guidelines are authored and maintained by Mayo’s departments of Anesthesiology and Transfusion Medicine, leveraging data from over 740,000 individual transfusion events.
CareSelect Blood features nearly 100 curated guidelines that are conservative, condition-driven and proven to work. Mayo’s AABB accreditation and advanced internal PBM program lend unmatched clinical expertise, while the CareSelect Platform (the market standard for imaging Clinical Decision Support) allows PBM content to be delivered directly into your native Electronic Health Record (EHR) workflow. The content can be accepted as is or localized to fit your organizational initiatives.
Patient Blood Management Done RightThe problem is simple: too many transfusions, too much waste, too much cost. However, the solution – up until this point – has been rather complicated. Current solutions lack the clinical breadth and technical infrastructure to fully tackle patient blood management across the continuum of care. CareSelect Blood combines PBM consulting and six clinical decision support modules that deliver everything you need to foster a successful PBM program to cut costs, reduce waste, and improve quality. It’s that simple.
CareSelect Blood Modules
Red Blood Cells
Reduce Risk, Reduce Volume, Reduce Cost
Blood is a finite and expensive resource that requires proper stewardship to prevent overuse. In the United States, blood transfusions rank in the top five overused medical interventions with the total number of transfusions doubling since 1997. This is not only wasteful but represents significant patient risk. Over 50,000 transfusion-related adverse reactions occur each year including allergic reactions, lung injuries, immune suppression, iron overload and renal failure.
Health systems across the country have seen significant reduction in usage by volume and total cost through the deployment of basic PBM protocols:
Monitor, Measure, Manage
CareSelect Blood – A Fully Integrated Approach to PBM
Our experience can inform your implementation and bridge the gap between quality, savings, and compliance. Across hundreds of health systems, NDSC has refined an expert CDS implementation approach to:
- Collect performance data without displaying interventions to identify high-value opportunities specific to your organization
- Benchmark data internally and against peer institutions to establish a baseline and internal goals for care quality
- Focus interventions to create early wins through the targeting of high-value areas of blood overuse
- Strategically expand implementations across the care continuum to foster provider buy-in and reduce alert fatigue
The Result? Reliable standards, reduced variation of care, and the data you need to improve performance. These factors lead to better patient care, improved population health, increased provider efficiency and lower cost of care.
CareSelect Blood in Action
Using the transfusion guidelines now contained in CareSelect Blood, Mayo Clinic Hospital – Rochester achieved a 33.6% reduction in overall volume that totaled $5.3 Million in annual savings:
Red Blood Cells (RBC)
35.3% reduction in volume (15,091 units )
$3.4 Million in savings*
Avg cost – $225/unit *
21.3% reduction in volume (2,570 units )
$1.4 Million in savings*
Avg cost – $535/unit *
44.3% reduction in volume (7,958 units )
$485k in savings*
Avg cost – $61 /unit*